Related Experiment Video
Updated: Jul 18, 2026

07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
The importance of vaccination
1Division of Immunology and Genetics, John Curtin School of Medical Research, Australian National University, Box 334, Canberra, ACT, 2601, Australia. Gordon.Ada@anu.edu.au
Frontiers in Bioscience : a Journal and Virtual Library
|November 28, 2006
Summary
Vaccines protect against many infectious diseases, but challenges remain for diseases like polio and HIV. New techniques may enable cell-mediated immunity vaccines for complex pathogens.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- Vaccines exist for ~30 of >70 human infectious diseases, with high efficacy and safety for most, especially childhood vaccines.
- Vaccine development is ongoing for various pathogens, but occasional withdrawals due to side effects and eradication challenges (e.g., smallpox, polio) persist.
- Emerging and re-emerging infectious diseases, notably HIV, pose significant threats lacking effective vaccines, necessitating novel approaches.
Purpose of the Study:
- To review the current state of vaccine development and efficacy.
- To highlight challenges in eradicating infectious diseases and developing vaccines for complex pathogens.
- To explore emerging technologies for novel vaccine strategies.
Main Methods:
- Review of existing vaccine landscape and historical eradication efforts.
- Analysis of challenges in vaccine development, including side effects and pathogen evolution.
- Discussion of new technological approaches for vaccine design.
Main Results:
- High success rates for vaccines against common childhood diseases are noted.
- Difficulties in polio eradication and the lack of an HIV vaccine are significant concerns.
- New techniques offer potential for vaccines inducing cell-mediated immunity.
Conclusions:
- While many vaccines are successful, challenges in eradication and for emerging diseases like HIV remain.
- The Sabin oral polio vaccine faces challenges with viral mutation and transmission.
- Advanced techniques may facilitate the development of cell-mediated immunity vaccines for difficult-to-target pathogens.
Related Concept Videos
Vaccinations
Overview
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

